The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Concept of Extremes in Vascular Aging: From Early Vascular Aging to Supernormal Vascular Aging
Abstract
With advancing age, changes in the arterial wall contribute to what has been called vascular aging, and in some prematurely affected subjects even early vascular aging (EVA).1–5 Several years ago,1 we listed various components of EVA, including arteriosclerosis, atherosclerosis, and excess vasoconstriction, with their clinical expression: arterial stiffening and increased central pulse pressure, carotid intima media thickening and endothelial dysfunction, and increased total peripheral resistance, respectively. In this review, we focus on arteriosclerosis, ie, arterial stiffening, for several reasons: this is the most characteristic clinical feature of the aging process of the arterial system,6 its measurement has been well standardized and referenced,7,8 and an increasing number of epidemiological studies have analyzed its independent determinants.9–11 Increased pulse wave velocity (PWV) is the established hallmark of arterial stiffening and is suggested to be one of the best biomarkers available to calculate the prospective cardiovascular risk and mortality risk of an individual.9,10,12,13 EVA can be diagnosed in subjects who present an abnormally high arterial stiffness for their age and sex.In the present review, we propose the concept of supernormal vascular aging (SUPERNOVA). SUPERNOVA can be diagnosed in subjects who present an exceptionally low arterial stiffness for their age and sex. We address the issue of the metrics and definition of EVA and SUPERNOVA as 2 extremes of the distribution of vascular aging. We discuss the concept of extremes in cardiometabolic research. Further, we review the molecular basis and mechanobiology of EVA and SUPERNOVA, in parallel with their epidemiological, genetic, and epigenetic determinants. Finally, we suggest therapeutic options and insist on the need for discovering novel molecular targets for slowing arterial aging and protecting against cardiovascular complications. By choosing the wording SUPERNOVA, we referred to the life of a supernova—a large explosion that takes place at the end of a star’s life cycle. The relationship between supernova and black hole is not firmly established, but physics theory states that in a black hole, time is slowed…like aging of arteries in SUPERNOVA subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Expert consensus document on arterial stiffness: methodological issues and clinical applications
Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., Pannier, B., Vlachopoulos, C., Wilkinson, I., Struijker-Boudier, H., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl254 · Cited by 6,077
Self-citationEstimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Laurent, S., Boutouyrie, P., Asmar, R., Gautier, I., Laloux, B., Guize, L., Ducimetiere, P., & Benetos, A. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1236 · Cited by 3,856
Self-citationLixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Pfeffer, M. A., Claggett, B., Diaz, R., Dickstein, K., Gerstein, H. C., Køber, L. V., Lawson, F. C., Ping, L., Wei, X., Lewis, E. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509225 · Cited by 2,409
Aortic Pulse Wave Velocity Improves Cardiovascular Event Prediction
Ben-Shlomo, Y., Spears, M., Boustred, C., May, M., Anderson, S. G., Benjamin, E. J., Boutouyrie, P., Cameron, J., Chen, C.-H., Cruickshank, J. K., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.063 · Cited by 1,835
Self-citationInterventions to slow aging in humans: are we ready?
Longo, V. D., Antebi, A., Bartke, A., Barzilai, N., Brown‐Borg, H. M., Caruso, C., Curiel, T. J., Cabo, R., Franceschi, C., Gems, D., et al. (2015) · Aging Cell · doi:10.1111/acel.12338 · Cited by 592 · cited 1×
“AMPK (AMP-activated protein kinase) activation: an energy-sensing kinase, promoting increased glucose uptake and enhanced fatty acid oxidation.(80) CR has also been studied in human(81) in the CALERIE trials”
BackgroundCherney, D. Z., Perkins, B. A., Soleymanlou, N., Har, R., Fagan, N., Johansen, O., Woerle, H.-J., von Eynatten, M., & Broedl, U. C. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-28 · Cited by 470
Cited by
Arterial Stiffness and Cardiovascular Risk in Hypertension
Boutouyrie, P., Chowienczyk, P., Humphrey, J. D., & Mitchell, G. F. (2021) · Circulation Research · doi:10.1161/circresaha.121.318061 · Cited by 748
Self-citationThe probabilistic model of Alzheimer disease: the amyloid hypothesis revised
Frisoni, G. B., Altomare, D., Thal, D. R., Ribaldi, F., van der Kant, R., Ossenkoppele, R., Blennow, K., Cummings, J., van Duijn, C., Nilsson, P. M., et al. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00533-w · Cited by 513
Self-citationBiological Versus Chronological Aging
Hamczyk, M. R., Nevado, R. M., Barettino, A., Fuster, V., & Andrés, V. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.062 · Cited by 489
Arterial Stiffness and Hypertension in the Elderly
Laurent, S., & Boutouyrie, P. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.544302 · Cited by 266
Self-citation
Metadata
- Authors
- Laurent, S., Boutouyrie, P., Cunha, P. G., Lacolley, P., & Nilsson, P. M.
- Venue
- Hypertension
- Published
- 2019-08
- Volume
- 74
- Issue
- 2
- Pages
- 218-228
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2963655570
- Cited by
- 225
- References
- 17
- FWCI
- 16.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Concept of Extremes in Vascular Aging: From Early Vascular Aging to Supernormal Vascular Aging. https://app.cochat.ai/papers/10.1161/hypertensionaha.119.12655
- The paper
- Laurent, S., Boutouyrie, P., Cunha, P. G., Lacolley, P., & Nilsson, P. M. (2019). Concept of Extremes in Vascular Aging: From Early Vascular Aging to Supernormal Vascular Aging. Hypertension. https://doi.org/10.1161/hypertensionaha.119.12655
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.